B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

P Selectin

300 PubMed studies analyzed · 1 RCTs · Evidence Score: 44.7

Research Domains

P Selectin has been studied across 16 research domains including 🔬 Oncology, ❤️ Cardiovascular, 🔬 Inflammation, 🛡️ Immunity, 🔥 Metabolic. The primary research focus is 🔬 Oncology with 18% of studies addressing this area.

Loading evidence profile...

This evidence profile for P Selectin is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.